A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy

We performed a two-stage genome-wide association study of IgA nephropathy (IgAN) in Han Chinese, with 1,434 affected individuals (cases) and 4,270 controls in the discovery phase and follow-up of the top 61 SNPs in an additional 2,703 cases and 3,464 controls. We identified associations at 17p13 (rs3803800, P = 9.40 × 10−11, OR = 1.21; rs4227, P = 4.31 × 10−10, OR = 1.23) and 8p23 (rs2738048, P = 3.18 × 10−14, OR = 0.79) that implicated the genes encoding tumor necrosis factor (TNFSF13) and α-defensin (DEFA) as susceptibility genes. In addition, we found multiple associations in the major histocompatibility complex (MHC) region (rs660895, P = 4.13 × 10−20, OR = 1.34; rs1794275, P = 3.43 × 10−13, OR = 1.30; rs2523946, P = 1.74 × 10−11, OR = 1.21) and confirmed a previously reported association at 22q12 (rs12537, P = 1.17 × 10−11, OR = 0.78). We also found that rs660895 was associated with clinical subtypes of IgAN (P = 0.003), proteinuria (P = 0.025) and IgA levels (P = 0.047). Our findings show that IgAN is associated with variants near genes involved in innate immunity and inflammation.

[1]  P. Zucchelli,et al.  [IgA nephropathy]. , 1985, Medicina clinica.

[2]  H. Cao,et al.  Human Leukocyte Antigen DRB1 Alleles Predict Risk and Disease Progression of Immunoglobulin A Nephropathy in Han Chinese , 2008, American Journal of Nephrology.

[3]  C. Forsblom,et al.  Increased levels of α-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy , 2007 .

[4]  S. Hsu Racial and genetic factors in IgA nephropathy. , 2008, Seminars in nephrology.

[5]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[6]  T. Kobayashi,et al.  Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset , 2009, Diabetologia.

[7]  R. Fischer-Betz,et al.  Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus , 2010, Lupus.

[8]  G. Hitman,et al.  HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations. , 1996, Kidney international.

[9]  Bor-Luen Chiang,et al.  Genetics and Immunopathogenesis of IgA Nephropathy , 2011, Clinical reviews in allergy & immunology.

[10]  B. Browning,et al.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.

[11]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[12]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[13]  F. Scolari Inherited forms of IgA nephropathy. , 2003, Journal of nephrology.

[14]  R. Hancock,et al.  Neutrophil-derived defensins as modulators of innate immune function. , 2008, Critical reviews in immunology.

[15]  R. Lifton,et al.  IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 , 2000, Nature Genetics.

[16]  R. Geha,et al.  Impaired IgA class switching in APRIL-deficient mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W. Klitz,et al.  HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. , 2007, Tissue antigens.

[18]  T. Ganz Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[19]  K. Matsushima,et al.  Urinary levels of chemokines (MCAF/MCP‐1, IL‐8) reflect distinct disease activities and phases of human IgA nephropathy , 1998, Journal of leukocyte biology.

[20]  Toshihiro Tanaka The International HapMap Project , 2003, Nature.

[21]  C. Forsblom,et al.  Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  M. Lévy,et al.  Worldwide perspective of IgA nephropathy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  J. He,et al.  Analysis of high‐resolution HLA‐A, ‐B, ‐Cw, ‐DRB1, and ‐DQB1 alleles and haplotypes in 718 Chinese marrow donors based on donor–recipient confirmatory typings , 2009, International journal of immunogenetics.

[24]  V. Jha,et al.  Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. “Current status and perspective of CKD in Asia”: diversity and specificity among Asian countries , 2009, Clinical and Experimental Nephrology.

[25]  Loreto Gesualdo,et al.  Genome-wide association study identifies susceptibility loci for IgA nephropathy , 2011, Nature Genetics.

[26]  K. Zerres,et al.  Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. , 2006, American journal of human genetics.

[27]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[28]  G. Robbins,et al.  Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects. , 2009, The Journal of infectious diseases.

[29]  J. L. le Petit,et al.  HLA-Bw35 and mesangial IgA glomerulonephritis. , 1978, The New England journal of medicine.

[30]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[31]  R. Lifton,et al.  Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. , 2006, Kidney international.

[32]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[33]  P. Seo,et al.  Renal Transplantation in the ANCA‐Associated Vasculitides , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  M. López‐Fraga,et al.  APRIL modulates B and T cell immunity. , 2002, The Journal of clinical investigation.

[35]  K. Tokunaga,et al.  Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese , 2006, Genes and Immunity.

[36]  F. Berthoux,et al.  HLA and IgA nephritis revisited 10 years later: HLA-B35 antigen as a prognostic factor. , 1988, The New England journal of medicine.

[37]  J. Clèdes,et al.  HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker of unfavorable outcome. , 1995, Tissue antigens.

[38]  Xiao-qing Liu,et al.  Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. , 2007, Journal of the American Society of Nephrology : JASN.

[39]  A. Plebani,et al.  Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. , 2007, Immunity.

[40]  B. Diamond,et al.  Similarities and differences between selective and nonselective BAFF blockade in murine SLE. , 2006, The Journal of clinical investigation.

[41]  M. Nakajima,et al.  Analysis of macrophages in urine sediments in children with IgA nephropathy. , 2004, Clinical nephrology.

[42]  Krzysztof Kiryluk,et al.  Genetic studies of IgA nephropathy: past, present, and future , 2010, Pediatric Nephrology.

[43]  D. Holdstock Past, present--and future? , 2005, Medicine, conflict, and survival.

[44]  Isabel Beerman,et al.  The genetics of IgA nephropathy , 2007, Nature Clinical Practice Nephrology.

[45]  G. D'Amico,et al.  The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.

[46]  Peter Dalgaard,et al.  R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .

[47]  A. Papagianni,et al.  Urinary levels of epidermal growth factor, interleukin‐6 and monocyte chemoattractant protein‐1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy , 2009, Nephrology.

[48]  W. Owen,et al.  Evidence for genetic factors in the development and progression of IgA nephropathy. , 2000, Kidney international.

[49]  É. Alamartine,et al.  Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril. , 1988 .

[50]  J. J. Morell Bernabé,et al.  [Schönlein-Henoch purpura and IgA nephropathy. A common pathogenetic cause?]. , 1990, Anales espanoles de pediatria.

[51]  E. Alexopoulos,et al.  Increased glomerular and interstitial LFA-1 expression in proteinuric immunoglobulin A nephropathy. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[52]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[53]  C. Cohen,et al.  Intrarenal production of B-cell survival factors in human lupus nephritis , 2011, Modern Pathology.

[54]  Pardis C Sabeti,et al.  A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.